Endocrinology Flashcards
(145 cards)
Antibodies associated with T1DM?
Anti-islet and anti-GAD
Diagnosis for diabetes on blood sugars?
Fasting > 7 / HbA1c >48mmol/L (6.5%)
2-hours post OGTT / Random glucose > 11.1mmol/L
What is the definition of impaired fasting glucose?
6.1 - 7.0
Offer these OGTT, If this is 7.8 - 11.1 = IMPAIRED GLUCOSE TOLERANCE
Conservative management of diabetes?
MDT
The 4 C’s? = Control, compilations, competency and coping
Diabetes conservative management - Control?
Record of complications e.g. DKA, HONK and hypo’s
CBG - target of 5-7 on waking and 4-7 pre-meal
HbA1c <6.5% or 48mmol/L
Check every 3-6 months then 6-monthly when stable
Control HTN - <140/80 if no end organ damage
<130/80 if end organ damage
What are BP targets for diabetics?
Control HTN - <140/80 if no end organ damage
<130/80 if end organ damage
Conservative management of diabetes - Complications?
Macro = Pulses, BP, cardiac
Micro = Fundoscopy, U&E’s and sensory testing
Conservative management of diabetes - Competency?
With insulin injections, checking injection sites and BM monitoring
Conservative management of diabetes - coping?
Psychological, occupational and domestic
Sick day rules for diabetes?
Increase frequency of blood sugars
Aim for at least 3 litres of fluid a day
Access to mobile and emergency food supplies
Continue all medication
Medical management of T1DM?
Always need insulin
Biphasic = first line = Twice daily insulin detemir
Management of type 2 diabetes - metformin tolerated?
If metformin tolerated it is 1st line
2nd line once HbA1c > 58mmol/L (7.5%) =
Add in gliptin / sulfonylurea / pioglitazone / SGLT-2 inhibitor
3rd line once HbA1c > 58mmol/L (7.5%) = metformin plus:
Sulfonylurea + gliptin
Sulfonylurea + pioglitazone
Sulfonylurea + SGLT-2 inhibitor
Pioglitazone + SGLT-2 inhibitor
3rd line = insulin
OR
Metformin + sulfonylurea + GLP-1 mimetic
When should you not use metformin?
End stage renal disease
Management of type 2 diabetes - metformin not tolerated?
1st line = gliptin or sulfonylurea or pioglitazone
2nd line once HbA1c >58mmol/L (7.5%):
Gliptin + pioglitazone
Gliptin + sulfonylurea
Pioglitazone + sulfonylurea
3rd line = insulin
When HbA1c hits what level do you move onto the next treatment in T2DM?
58 mmol/L or 7.5%
When can you use metformin + sulfonylurea + GLP-1 mimetic?
When normal triple therapy not effective (3rd line), then use this if BMI >35, or BMI<35 but weight loss or using insulin would have a big impact
Metformin - MOA, SE’s and CI’s?
Increases insulin sensitivity + decreases hepatic neogenesis
Nausea, diarrhoea, abdominal pain, lactic acidosis
Cannot use if eGFR <30ml/minute
Sulfonylureas - Examples, MOA, SE’s?
Gliclazide or Glimepiride
Stimulate pancreatic beta cells to stimulate insulin
SE’s = hypoglycaemia, WEIGHT GAIN, hyponatraemia
Thiazolidinediones - Example, MOA, SE’s?
Pioglitazone (contraindicated in blander cancer and heart failure)
Activate PPAR-gamma receptor in adipocytes to promote adipogenesis and fatty acid reuptake, reducing peripheral insulin resistance
SE’s = Weight gain and fluid retention
DPP-4 inhibitors / Gliptins - examples, MOA and SE’s?
Vildagliptin and sitagliptin
Increases incretin levels which inhibit glucagon secretion
SE = increased risk of pancreatitis
SGLT-2 inhibitors - MOA, SE’s?
-Gliflozins
Inhibit resorption of glucose in the kidneys - typically results in WEIGHT LOSS
SE’s = UTI as more glucose in the urine
GLP-1 agonists - How do you take it, MOA and SE’s?
Exanitide
Subcut
Incretin mimetic which inhibits glucagon secretion - typically results in WEIGHT LOSS
SE’s = N&V, pancreatitis
Macrovascular complications of diabetes?
MI/CVA
Microvascular complications of diabetes?
Diabetic foot
Nephropathy
Retinopathy
Neuropathy